Abstract:Objectives: Retinal vein occlusion (RVO) is the second most common retinal vascular disease worldwide, and the retinal perfusion status is closely related to the prognosis of the disease. Macular perfusion status is particularly correlated with visual acuity. This study aims to investigate the changes in macular perfusion indicators in RVO using optical coherence tomography angiography (OCTA) and analyze the correlation between macular perfusion status and visual acuity. Methods: This cross-sectional study included 41 RVO patients, who were divided into 2 groups based on the occlusion site: 18 cases in the central retinal vein occlusion (CRVO) group and 23 cases in the branch retinal vein occlusion (BRVO) group. Additionally, they were categorized into ischemic RVO (23 cases) and non-ischemic RVO (16 cases) groups based on the presence of ischemia (2 eyes were excluded due to hemorrhage obscuring the peripheral retina, making it impossible to confirm the area of non-perfusion). A control group of 29 healthy individuals matched by sex and age was also recruited. Macular perfusion indicators were measured using OCTA, and the correlation between macular perfusion status and visual acuity was analyzed. Results: Compared with healthy eyes, RVO eyes showed an increased foveal avascular zone (FAZ) area and significantly reduced superficial and deep vessel density (P<0.001). However, there were no significant differences in central foveal thickness (CFT) or macular perfusion indicators between the CRVO and BRVO groups (P>0.05). The best corrected visual acuity (BCVA) at the logarithm of the minimum angle of resolution (logMAR BCVA) was significantly negatively correlated with both superficial and deep retinal vessel density in RVO eyes (unstandardized coefficient B=-0.039, B=-0.042; P=0.017, P=0.040). The average BCVA in the ischemic RVO group was significantly worse than that in the non-ischemic RVO group (0.82±0.44 vs 0.45±0.29, P=0.007). The ischemic RVO group also had a larger FAZ area (P=0.003) and lower superficial and deep retinal vessel density (P<0.001, P=0.008, respectively) compared with the non-ischemic RVO group. The severity of macular ischemia did not correspond directly with the peripheral ischemia severity in RVO. Conclusions: Macular perfusion status is significantly reduced in RVO eyes compared to healthy eyes, which negatively impacts and limits visual acuity in RVO patients. Eyes with ischemic RVO have poorer visual acuity and macular perfusion status than those with non-ischemic RVO. OCTA is advantageous for observing vascular morphology and quantifying macular perfusion status, making it an effective tool for assessing disease progression.

Whole course management is the key to retinal vein occlusion

Refocusing on the Etiology and Pathology of Retinal Vein Occlusion to Guide Clinical Practice

Retinal vein occlusion: Modern approaches to treatment

RETINAL VEIN OCCLUSIONS, FROM BASICS TO THE LATEST TREATMENT.

Study progression in the treatment of central retinal vein occlusion

Be cautious of using anti-vascular endothelial growth factor therapy for treatment of macular edema secondary to retinal vein occlusion

A retrospective study assessing the factors associated with visual outcome in retinal vein occlusion patients after anti-VEGF therapy

Photocoagulation for retinal vein occlusion

[Ischemia and laser photocoagulation in retinal vein occlusion]

Chorioretinal venous anastomosis for non-ischemic retinal vein occlusion

Analyze of Factors and Prognosis of Eyes Lost to Follow-Up in Retinal Vein Occlusive Disease Patients Receiving Anti-Vascular Endothelial Growth Factor Therapy

Clinical utility of ultra-widefield fluorescein angiography and optical coherence tomography angiography for retinal vein occlusions

[The Rational Use of Anti-Vascular Endothelial Growth Factor Drugs to Assist the Treatment of Diabetic Retinopathy].

Correlation between macular perfusion status and visual acuity in retinal vein occlusion

Roles of hypoxia and inflammation in the pathogenesis of macular edema secondary to retinal vein occlusion

The progress of assessment methods and treatments of neovascular glaucoma secondary to central retinal vein occlusion

Analysis of visual prognosis and correlative factors in retinal vein occlusion

Intravitreal Anti-Vegf Agents, Oral Glucocorticoids, And Laser Photocoagulation Combination Therapy For Macular Edema Secondary To Retinal Vein Occlusion: Preliminary Report

Advances on treatment for retinal vein occlusion

Visual and anatomical outcomes following intravitreal treatment of macular oedema secondary to retinal vein occlusion

Multimodal Imaging of Microvascular Abnormalities in Retinal Vein Occlusion